Wellington Management Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-130,044
Closed -$4.55M 2006
2024
Q1
$4.55M Sell
130,044
-15,354
-11% -$560K ﹤0.01% 1341
2023
Q4
$5.53M Sell
145,398
-29,501
-17% -$632K ﹤0.01% 1277
2023
Q3
$3.21M Buy
174,899
+34,310
+24% +$718K ﹤0.01% 1386
2023
Q2
$3.65M Buy
140,589
+37,692
+37% +$880K ﹤0.01% 1344
2023
Q1
$1.94M Sell
102,897
-798,085
-89% -$18.6M ﹤0.01% 1524
2022
Q4
$22.2M Sell
900,982
-111,758
-11% -$3.29M ﹤0.01% 890
2022
Q3
$18.2M Buy
1,012,740
+590,536
+140% +$10.6M ﹤0.01% 937
2022
Q2
$4.79M Buy
422,204
+303,698
+256% +$4.47M ﹤0.01% 1333
2022
Q1
$2.64M Sell
118,506
-1,381,018
-92% -$35.3M ﹤0.01% 1541
2021
Q4
$65.5M Sell
1,499,524
-286,508
-16% -$11.5M 0.01% 751
2021
Q3
$59.5M Sell
1,786,032
-360,163
-17% -$11M 0.01% 764
2021
Q2
$59.1M Buy
2,146,195
+169,714
+9% +$3.53M 0.01% 770
2021
Q1
$39.7M Buy
+1,976,481
New +$57.7M 0.01% 875
2020
Q4
Sell
-20,202
Closed -$364K 2078
2020
Q3
$364K Buy
+20,202
New +$366K ﹤0.01% 1774

Other funds holding INBX

Wellington Management Group's INBX Position: Q2 2024 in Review

Wellington Management Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 130,044 shares — an estimated $4.55M sold.

Wellington Management Group first reported a position in INBX in Q3 2020 and held it in 14 quarters. The position peaked at $65.5M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Wellington Management Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wellington Management Group sold 130,044 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $4.55M.
  • Wellington Management Group first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Wellington Management Group's Inhibrx, Inc. Common Stock position peaked at $65.5M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.